Semaglutide GLP-1 for weight loss is available at Noor Medical Spa
Prices expected to drop by 5090%, improving accessibility Monthly therapy cost potentially reduced from 10,000+ to as low as 1,5004,000 40+ pharma companies preparing to launch generics Over 50 brands expected in the market Why this matters: Semaglutide, a GLP-1 analog, has transformed management of Type 2 Diabetes & Obesity by improving glycemic control and enabling significant weight loss
Alcohol sensitivity often increases dramatically on GLP-1 therapy
Rahi Sarbaziha, a Los Angelesbased double board-certified anti-aging and integrative aesthetics doctor
Its ability to regulate appetite, reduce cravings, and support consistent weight loss has made it one of the most sought-after non-surgical options for people looking to transform their bodies and health